US Stock MarketDetailed Quotes

GDRX GoodRx

Watchlist
  • 8.850
  • +0.110+1.26%
Trading Jul 26 09:55 ET
3.32BMarket Cap-590000P/E (TTM)

GoodRx Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

GoodRx Earnings Date

Currency: USD

Period

Q2 FY2024 Estimates

Aug 8, 2024

Revenue(YoY)

200.48M

+5.69%
EPS(YoY)

0.03

-76.86%
Analyst Rating

Buy

Jul 26, 2024

GoodRx Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 14 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 202.494M--
Aug 8, 20242024/Q2-- / 200.478M--
May 9, 20242024/Q1197.880M / 196.098M--
Feb 29, 20242023/Q4196.644M / 195.873M--
Nov 9, 20232023/Q3179.958M / 188.258M--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 202.494M--
Aug 8, 20242024/Q2-- / 200.478M--
May 9, 20242024/Q1197.880M / 196.098M--
Feb 29, 20242023/Q4196.644M / 195.873M--
Nov 9, 20232023/Q3179.958M / 188.258M--

Unlock Free Earnings Estimates

GoodRx Earnings Reports

  • GoodRx | 10-Q: Quarterly report

    May 9 15:58 ET

  • GoodRx | 10-K: Annual report

    Feb 29 14:09 ET

  • GoodRx: Q3 2023 Earnings Report

    Nov 9, 2023 14:21 ET

  • GoodRx | 10-Q: Q2 2023 Earnings Report

    Aug 9, 2023 14:42 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Jul 26, 2024

    Buy

    • Buy

      57.14%

    • Hold

      35.71%

    • Sell

      7.14%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    % Chg